3 results on '"Zhang, Y.L."'
Search Results
2. Tropospheric volatile organic compounds in China.
- Author
-
Guo, H., Ling, Z.H., Cheng, H.R., Simpson, I.J., Lyu, X.P., Wang, X.M., Shao, M., Lu, H.X., Ayoko, G., Zhang, Y.L., Saunders, S.M., Lam, S.H.M., Wang, J.L., and Blake, D.R.
- Subjects
- *
TROPOSPHERIC chemistry , *VOLATILE organic compounds & the environment , *PHOTOCHEMISTRY , *ATMOSPHERIC ozone - Abstract
Photochemical smog, characterized by high concentrations of ozone (O 3 ) and fine particles (PM 2.5 ) in the atmosphere, has become one of the top environmental concerns in China. Volatile organic compounds (VOCs), one of the key precursors of O 3 and secondary organic aerosol (SOA) (an important component of PM 2.5 ), have a critical influence on atmospheric chemistry and subsequently affect regional and global climate. Thus, VOCs have been extensively studied in many cities and regions in China, especially in the North China Plain, the Yangtze River Delta and the Pearl River Delta regions where photochemical smog pollution has become increasingly worse over recent decades. This paper reviews the main studies conducted in China on the characteristics and sources of VOCs, their relationship with O 3 and SOA, and their removal technology. This paper also provides an integrated literature review on the formulation and implementation of effective control strategies of VOCs and photochemical smog, as well as suggestions for future directions of VOCs study in China. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
3. Deep Vein Thrombosis in Hospitalized Patients With COVID-19 in Wuhan, China: Prevalence, Risk Factors, and Outcome.
- Author
-
Zhang L, Feng X, Zhang D, Jiang C, Mei H, Wang J, Zhang C, Li H, Xia X, Kong S, Liao J, Jia H, Pang X, Song Y, Tian Y, Wang B, Wu C, Yuan H, Zhang Y, Li Y, Sun W, Zhang Y, Zhu S, Wang S, Xie Y, Ge S, Zhang L, Hu Y, and Xie M
- Subjects
- Adult, Aged, Anticoagulants therapeutic use, Betacoronavirus isolation & purification, Blood Pressure, COVID-19, China epidemiology, Coronavirus Infections complications, Coronavirus Infections mortality, Coronavirus Infections physiopathology, Female, Fibrin Fibrinogen Degradation Products analysis, Humans, Kaplan-Meier Estimate, Lower Extremity diagnostic imaging, Male, Middle Aged, Odds Ratio, Pandemics, Pneumonia, Viral complications, Pneumonia, Viral mortality, Pneumonia, Viral physiopathology, Prevalence, Prognosis, Respiratory Rate, Retrospective Studies, Risk Factors, SARS-CoV-2, Treatment Outcome, Venous Thrombosis complications, Venous Thrombosis drug therapy, Venous Thrombosis epidemiology, Coronavirus Infections diagnosis, Pneumonia, Viral diagnosis, Venous Thrombosis diagnosis
- Abstract
Background: To investigate deep vein thrombosis (DVT) in hospitalized patients with coronavirus disease 2019 (COVID-19), we performed a single institutional study to evaluate its prevalence, risk factors, prognosis, and potential thromboprophylaxis strategies in a large referral and treatment center., Methods: We studied a total of 143 patients with COVID-19 from January 29, 2020 to February 29, 2020. Demographic and clinical data, laboratory data, including ultrasound scans of the lower extremities, and outcome variables were obtained, and comparisons were made between groups with and without DVT., Results: Of the 143 patients hospitalized with COVID-19 (age 63±14 years, 74 [51.7%] men), 66 patients developed lower extremity DVT (46.1%: 23 [34.8%] with proximal DVT and 43 [65.2%] with distal DVT). Compared with patients who did not have DVT, patients with DVT were older and had a lower oxygenation index, a higher rate of cardiac injury, and worse prognosis, including an increased proportion of deaths (23 [34.8%] versus 9 [11.7%]; P =0.001) and a decreased proportion of patients discharged (32 [48.5%] versus 60 [77.9%]; P <0.001). Multivariant analysis showed an association only between CURB-65 (confusion status, urea, respiratory rate, and blood pressure) score 3 to 5 (odds ratio, 6.122; P =0.031), Padua prediction score ≥4 (odds ratio, 4.016; P =0.04), D-dimer >1.0 μg/mL (odds ratio, 5.818; P <0.014), and DVT in this cohort, respectively. The combination of a CURB-65 score 3 to 5, a Padua prediction score ≥4, and D-dimer >1.0 μg/mL has a sensitivity of 88.52% and a specificity of 61.43% for screening for DVT. In the subgroup of patients with a Padua prediction score ≥4 and whose ultrasound scans were performed >72 hours after admission, DVT was present in 18 (34.0%) patients in the subgroup receiving venous thromboembolism prophylaxis versus 35 (66.0%) patients in the nonprophylaxis group ( P =0.010)., Conclusions: The prevalence of DVT is high and is associated with adverse outcomes in hospitalized patients with COVID-19. Prophylaxis for venous thromboembolism may be protective in patients with a Padua protection score ≥4 after admission. Our data seem to suggest that COVID-19 is probably an additional risk factor for DVT in hospitalized patients.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.